These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11268151)

  • 21. Where was Crohn's colitis in 1932?
    Levine J
    J Clin Gastroenterol; 1989 Apr; 11(2):187-92. PubMed ID: 2661659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autonomic cardiovascular regulation in quiescent ulcerative colitis and Crohn's disease.
    Coruzzi P; Castiglioni P; Parati G; Brambilla V; Brambilla L; Gualerzi M; Cademartiri F; Franzè A; De Angelis G; Di Rienzo M; Di Mario F
    Eur J Clin Invest; 2007 Dec; 37(12):964-70. PubMed ID: 18036030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The comorbid occurrence of other diagnoses in patients with ulcerative colitis and Crohn's disease.
    Cucino C; Sonnenberg A
    Am J Gastroenterol; 2001 Jul; 96(7):2107-12. PubMed ID: 11467640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease.
    Dotan I; Fishman S; Dgani Y; Schwartz M; Karban A; Lerner A; Weishauss O; Spector L; Shtevi A; Altstock RT; Dotan N; Halpern Z
    Gastroenterology; 2006 Aug; 131(2):366-78. PubMed ID: 16890590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
    Annese V; Piepoli A; Perri F; Lombardi G; Latiano A; Napolitano G; Corritore G; Vandewalle P; Poulain D; Colombel JF; Andriulli A
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1143-52. PubMed ID: 15569117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn's disease.
    Guthrie E; Jackson J; Shaffer J; Thompson D; Tomenson B; Creed F
    Am J Gastroenterol; 2002 Aug; 97(8):1994-9. PubMed ID: 12190166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hla-B genotype in Japanese patients with Crohn's disease.
    Kinouchi Y; Matsumoto K; Negoro K; Takagi S; Takahashi S; Hiwatashi N; Shimosegawa T
    Dis Colon Rectum; 2003 Oct; 46(10 Suppl):S10-4. PubMed ID: 14530653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease.
    Canavan C; Abrams KR; Mayberry J
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1097-104. PubMed ID: 16611269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
    Latiano A; Palmieri O; Valvano MR; D'Incà R; Caprilli R; Cucchiara S; Sturniolo GC; Bossa F; Andriulli A; Annese V
    Aliment Pharmacol Ther; 2008 Feb; 27(3):241-8. PubMed ID: 17944996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psoriasis associated with ulcerative colitis and Crohn's disease.
    Cohen AD; Dreiher J; Birkenfeld S
    J Eur Acad Dermatol Venereol; 2009 May; 23(5):561-5. PubMed ID: 19207663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased expression of VEGF and CD146 in patients with inflammatory bowel disease.
    Tsiolakidou G; Koutroubakis IE; Tzardi M; Kouroumalis EA
    Dig Liver Dis; 2008 Aug; 40(8):673-9. PubMed ID: 18374637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different distribution of mast cells and macrophages in colonic mucosa of patients with collagenous colitis and inflammatory bowel disease.
    Nishida Y; Murase K; Isomoto H; Furusu H; Mizuta Y; Riddell RH; Kohno S
    Hepatogastroenterology; 2002; 49(45):678-82. PubMed ID: 12063968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular evidence for Mycobacterium avium subspecies paratuberculosis (MAP) in Crohn's disease correlates with enhanced TNF-alpha secretion.
    Clancy R; Ren Z; Turton J; Pang G; Wettstein A
    Dig Liver Dis; 2007 May; 39(5):445-51. PubMed ID: 17317344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
    Roblin X; Serre-Debeauvais F; Phelip JM; Faucheron JL; Hardy G; Chartier A; Helluwaert F; Bessard G; Bonaz B
    Aliment Pharmacol Ther; 2005 Apr; 21(7):829-39. PubMed ID: 15801918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CARD15 in inflammatory bowel disease and Crohn's disease phenotypes: an association study and pooled analysis.
    Oostenbrug LE; Nolte IM; Oosterom E; van der Steege G; te Meerman GJ; van Dullemen HM; Drenth JP; de Jong DJ; van der Linde K; Jansen PL; Kleibeuker JH
    Dig Liver Dis; 2006 Nov; 38(11):834-45. PubMed ID: 16920047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term outcome of surgically treated Crohn's colitis: a prospective study.
    Fichera A; McCormack R; Rubin MA; Hurst RD; Michelassi F
    Dis Colon Rectum; 2005 May; 48(5):963-9. PubMed ID: 15785882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibodies to Saccharomyces cerevisiae: are they useful in clinical practice?
    Candelli M; Papa A; Nista EC; Danese S; Armuzzi A; Bartolozzi F; Tondi P; Ojetti V; Gasbarrini G; Gasbarrini A
    Hepatogastroenterology; 2003; 50(51):718-20. PubMed ID: 12828069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Orthopaedic research and education foundation and industry.
    Wurth GR; Sherr JH; Coffman TM
    Clin Orthop Relat Res; 2003 Jul; (412):54-6. PubMed ID: 12838052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease.
    Winterkamp S; Weidenhiller M; Otte P; Stolper J; Schwab D; Hahn EG; Raithel M
    Am J Gastroenterol; 2002 Dec; 97(12):3071-7. PubMed ID: 12492192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.